{"id":321,"date":"2007-04-12T18:11:03","date_gmt":"2007-04-12T22:11:03","guid":{"rendered":"http:\/\/piel-l.org\/blog\/?p=321"},"modified":"2007-04-13T09:25:15","modified_gmt":"2007-04-13T13:25:15","slug":"terapia-antiandrogenica","status":"publish","type":"post","link":"https:\/\/piel-l.org\/blog\/321","title":{"rendered":"Terapia antiandrog\u00e9nica"},"content":{"rendered":"<p><strong>Aporte del Dr. Jaime Piquero Mart\u00edn<\/strong>&nbsp;<\/p>\n<p><strong>Un grupo de pacientes femeninas  que nos consultan por acn\u00e9 pueden ser controladas con terapia antiandrogenica<\/strong><\/p>\n<p><strong>\u00bf;A que pacientes le realizamos investigaci\u00f3n de  anormalidad endocrina?<\/strong><\/p>\n<blockquote>\n<p><strong>&#8211; <\/strong>Repentino brote de acn\u00e9&nbsp; severo de  inicio<br \/> &#8211; Acn\u00e9 refractario a tratamiento convencional<br \/> &#8211; Acn\u00e9 asociado a hirsutismo<br \/> &#8211; Per\u00edodos menstruales irregulares<br \/> &#8211; Otros signos de hiperandrogenismo<\/p>\n<\/blockquote>\n<p><!--more--><\/p>\n<p><strong>\u00bf;Que ex\u00e1menes hormonales solicitamos?<\/strong><\/p>\n<blockquote>\n<ol>\n<li>Testosterona total y libre&nbsp;&nbsp;<\/li>\n<li>Androstenediona&nbsp;<\/li>\n<li>Sulfato de DHEA<\/li>\n<li>FSH\/LH<\/li>\n<li>Curva de tolerancia glucosada y de insulina 0, 60, 120 minutos con  sobrecarga de 75 gramos<\/li>\n<\/ol>\n<\/blockquote>\n<p> <\/p>\n<p><strong>\u00bf;En que momento debe hacerse la toma de la  muestra?<\/strong><\/p>\n<blockquote>\n<p>En los primeros 5 d\u00edas si es c\u00edclica, en  cualquier momento si no lo es<\/p>\n<\/blockquote>\n<p><strong>Anticonceptivos que pueden usarse como coadyuvante de la terapia del  acn\u00e9 constitucional<\/strong><\/p>\n<blockquote>\n<p> &#8211; Ciproterone  acetate 2 mg\/ethinyl estradiol 35 mcg. (Diane-35)<br \/> &#8211; Drosperinona 3 mg + etinilestradiol 0.03 mg:&nbsp; (Yasmin)<br \/> &#8211; Ethinyl  estradiol\/chlormadinone acetate (Belara)<br \/> &#8211; Ethinyl  estradiol\/levonorgestrel (Alese)<br \/> &#8211; Norethindrone  acetate 1,000 mcg\/ethinyl estradiol 20-30-35 mcg&nbsp;<br \/> &#8211; Norgestimate  180-215-250 mcg\/ethinyl estradiol 35 mcg&nbsp;<\/p>\n<\/blockquote>\n<p><strong>Otros antiandr\u00f3genos  que pueden utilizarse cuando el acn\u00e9 coexiste con androgenizaci\u00f3n<\/strong><\/p>\n<blockquote>\n<p>1.-Los  antiandr\u00f3genos que realizan su acci\u00f3n bloqueando los receptores nucleares son: Espironolactona,  Acetato de Ciproterona, Flutamida<br \/> 2.-Otros bloqueadores de&nbsp; receptores nucleares de diferenciacion del  sebocito: Metformina, Bromocriptina, Inhibidores de la hormona tiroidea<br \/> 3.- Frenadores de  los andr\u00f3genos producidos por el ovario: Estr\u00f3genos, Anticonceptivos  orales, Acetato de Ciproterona<br \/> 4.-Bloqueadores de los andr\u00f3genos producidos  por la suprarrenal: Anticonceptivos orales plus baja dosis de  glucocorticoides<br \/> 5.- Inhibidores de  las enzimas citoplasm\u00e1ticas del sebocito: Inhibidores de la 5 alfa reductasa:  Finasteride<\/p>\n<\/blockquote>\n<p><strong>Harper JC. Antiandrogen therapy for skin and  hair disease.Dermatol Clin. 2006 Apr;24(2):137-43. <\/strong><\/p>\n<p>Androgen  hormones play an important role in common skin and hair conditions including  acne vulgaris, hirsutism, and androgenetic alopecia. Blocking this androgen  effect may lead to significant improvements in these conditions. Several  medications that work through a variety of different mechanisms may be prescribed  safely and effectively as antiandrogen therapies in the dermatology arena.<\/p>\n<p><strong>Zouboulis CC. [Treatment of acne with  antiandrogens&#8211;an evidence-based review] J Dtsch Dermatol Ges. 2003  Jul;1(7):535-46<\/strong><\/p>\n<p>Increased  sebaceous gland activity with seborrhea is one of the major  pathogenetic factors in acne. Antiandrogen treatment targets the androgen-metabolizing  follicular keratinocytes and the sebaceous gland leading to  sebostasis, with a reduction of the sebum secretion rate of 12.5-65%. Antiandrogens  can be classified based on their mechanism of action as androgen receptor  blockers, inhibitors of circulating androgens by affecting ovarian function  (oral contraceptives), inhibitors of circulating androgens by affecting the  pituitary (gonadotropin-releasing hormone agonists and dopamine agonists in hyperprolactinemia),  inhibitors of adrenal function, and inhibitors of peripheral  androgen metabolism (5alpha-reductase inhibitors, inhibitors of other enzymes).  METHODS: All original and review publications on antiandrogen treatment  of acne as monotherapy or in combination included in the MedLine system were  extracted by using the terms &quot;acne&quot;, &quot;seborrhea&quot;,  &quot;polycystic ovary syndrome&quot;,  &quot;hyperandrog&quot;, and &quot;treatment&quot; and classified according to  their level of  evidence. RESULTS: The combinations of cyproterone acetate (2 mg)\/ethinyl  estradiol (35 microg), drospirenone (3 mg)\/ethinyl estradiol (30 microg),  and desogestrel (25 microg)\/ ethinyl estradiol (40 microg) for 1 week followed by  desogestrel (125 microg)\/ethinyl estradiol (30 microg) for 2 weeks showed the  strongest anti-acne activity. Gestagens or estrogens as monotherapy, spironolactone,  flutamide, gonadotropin-releasing hormone agonists, and inhibitors  of peripheral androgen metabolism cannot be endorsed based on current knowledge.  Low dose prednisolone is only effective in late-onset congenital adrenal  hyperplasia and dopamine agonists only in hyperprolactinemia. Treatment with  antiandrogens should only be considered if none of the contraindications exist.  CONCLUSION: Antiandrogen treatment should be limited to female patients with  additional signs of peripheral hyperandrogenism or hyperandrogenemia. In addition,  women with late-onset or recalcitrant acne who also desire contraception  can be treated with antiandrogens as can those being treated with systemic  isotretinoin. Antiandrogen treatment is not appropriate primary monotherapy for noninflammatory and mild  inflammatory acne.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Aporte del Dr. Jaime Piquero Mart\u00edn&nbsp; Un grupo de pacientes femeninas que nos consultan por acn\u00e9 pueden ser controladas con terapia antiandrogenica \u00bf;A que pacientes le realizamos investigaci\u00f3n de anormalidad endocrina? &#8211; Repentino brote de acn\u00e9&nbsp; severo de inicio &#8211; Acn\u00e9 refractario a tratamiento convencional &#8211; Acn\u00e9 asociado a hirsutismo &#8211; Per\u00edodos menstruales irregulares &#8211; &hellip;<\/p>\n","protected":false},"author":13,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-321","post","type-post","status-publish","format-standard","","category-generales"],"_links":{"self":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/posts\/321","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/comments?post=321"}],"version-history":[{"count":0,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/posts\/321\/revisions"}],"wp:attachment":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/media?parent=321"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/categories?post=321"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/tags?post=321"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}